Drug profile · INN
nefazodone hydrochloride
NEFAZODONE HYDROCHLORIDE
nefazodone hydrochloride (NEFAZODONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — nefazodone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
nefazodone hydrochloride (NEFAZODONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2a (5-HT2a) receptor antagonist
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nefazodone hydrochloride?
nefazodone hydrochloride (NEFAZODONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nefazodone hydrochloride?
NEFAZODONE HYDROCHLORIDE is a marketed brand name for nefazodone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nefazodone hydrochloride?
nefazodone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.